Dukascopy releases next-gen JForex 3 platform


jforex 3 fx trading platform

Dukascopy Bank, the FINMA regulated Switzerland-based Forex brokerage announced it released a new generation of the JForex platform – JForex 3 with higher performance and better user experience.

After the platform’s trial launch in September 2016, JForex 3 successfully passed the company’s probation period and has become available on live accounts.

Dukascopy stated:

During the probation period, Dukascopy DEMO users proved their preference in favor of the new JForex 3 over the current version.

The new JForex 3 platform has an interface similar to the current version of JForex platform, making the acquaintance easier for users that are already familiar with JForex.

JForex 3 is available simultaneously with the current generation of JForex, allowing users to continue trading on the current version of the platform if they wish to do so.

The new JForex 3 platform has new features such as zoom function, drag&drop (personally adjustable interface), over 35 new trading indicators, advanced indicator setting (e.g. possibility to build new indicators based on the output of other indicators, different instruments, periods etc.), order pop-up notifications, new types of trading amounts (lots, M, K) and a new design with different color themes.

Since the release of the previous generation of JForex, Dukascopy has significantly increased the number of trading instruments, including new currency pairs, CFDs on commodities, indexes and equities, and is planning to continue extending the list. Among other improvements, the new JForex 3 makes it easier to search and subscribe to different trading instruments.

The full list of new features can be found here.

Related News

arrow

Dukascopy releases next-gen JForex 3 platform

5

Send this to a friend

Fill out the form below for more information
for lising in LeapRate's Forex Yellow Pages

Please enter the company name, email address to reach you and phone # (optional):

Please fill out the message field to the right for any questions or special inquiry: